Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 4 (2007), Issue 10 (October)

1. Predictors of fitness to drive in people with Parkinson disease.
   Neurology, 69(14): 1434-41. [Abstract] [Full-text]
2. Fast-track programming and rehabilitation model: a novel approach to postoperative deep brain stimulation patient care.
   Arch Phys Med Rehabil, 88(10): 1320-4. [Abstract] [Full-text]
3. Validity of the trunk impairment scale as a measure of trunk performance in people with Parkinson's disease.
   Arch Phys Med Rehabil, 88(10): 1304-8. [Abstract] [Full-text]
4. Reliability and validity of the Tinetti Mobility Test for individuals with Parkinson disease.
   Phys Ther, 87(10): 1369-78. [Abstract] [Full-text]
5. PARK10 candidate RNF11 is expressed by vulnerable neurons and localizes to Lewy bodies in Parkinson disease brain.
   J Neuropathol Exp Neurol, 66(10): 955-64. [Abstract] [Full-text]
6. The future of cell therapies in the treatment of Parkinson's disease.
   Expert Opin Biol Ther, 7(10): 1487-98. [Abstract] [Full-text]
7. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
   Neurology, 69(16): 1595-602. [Abstract] [Full-text]
8. Hemiparkinsonism-hemiatrophy syndrome.
   Neurology, 69(16): 1585-94. [Abstract] [Full-text]
9. Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation.
   Neurology, 69(16): 1580-4. [Abstract] [Full-text]
10. The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine.
    J Neurol Neurosurg Psychiatry, 78(11): 1191-8. [Abstract] [Full-text]
11. Cognitive impairment in Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 78(11): 1182-7. [Abstract] [Full-text]
12. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 78(11): 1188-90. [Abstract] [Full-text]
13. Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.
    Ann Pharmacother, 41(11): 1842-9. [Abstract] [Full-text]
14. Beating a dead horse: dopamine and Parkinson disease.
    Neurology, 69(17): 1701-11. [Abstract] [Full-text]
15. Gout and risk of Parkinson disease: a prospective study.
    Neurology, 69(17): 1696-700. [Abstract] [Full-text]
16. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
    Neurology, 69(17): 1688-95. [Abstract] [Full-text]
17. Apomorphine therapy in Parkinson's disease: a review.
    Expert Opin Pharmacother, 8(16): 2799-809. [Abstract] [Full-text]
18. Body mass index and risk of Parkinson's disease: a prospective cohort study.
    Am J Epidemiol, 166(10): 1186-90. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.